Arthritis, Rheumatoid, drug therapy
- Name
- Arthritis, Rheumatoid, drug therapy
- Accession Number
- DBCAT002793
- Description
Not Available
- Drugs
Drug Drug Description Pateclizumab Pateclizumab is under investigation in clinical trial NCT01225393 (A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in... Filgotinib A Janus kinase (JAK) 1 selective inhibitor used to treat cases of rheumatoid arthritis that are unresponsive to conventional treatments. - Drugs & Drug Targets
Drug Target Type Filgotinib Tyrosine-protein kinase JAK1 target Filgotinib Cocaine esterase enzyme Filgotinib Liver carboxylesterase 1 enzyme Filgotinib P-glycoprotein 1 transporter